Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.

Saved in:
Bibliographic Details
Title: Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.
Authors: Tang ASP; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Hsu JTY; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Chong SKS; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Quek J; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Shek G; Wallace Wurth, University of New South Wales, Sydney, NSW, Australia., Sulaimi F; Wallace Wurth, University of New South Wales, Sydney, NSW, Australia., Chan KE; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Anand VV; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Chong B; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Mehta A; Virginia Commonwealth University Health Pauley Heart Center, Division of Cardiology (A.M.), Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, USA., Toh SA; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Medicine, National University Hospital, Singapore, Singapore.; NOVI Health, Singapore, Singapore.; Regional Health System Office, National University Health System, Singapore, Singapore., Muthiah M; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore., Dimitriadis GK; Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, London, UK.; Obesity, Type 2 Diabetes and Immunometabolism Research Group, Department of Diabetes, Faculty of Cardiovascular Medicine & Sciences, School of Life Course Sciences, King's College London, London, UK., le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.; Diabetes Research Centre , Ulster University , UK, UK., Chan MY; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore., Mamas MA; Keele Cardiac Research Group, Keele University, Stoke-on-Trent, UK., Chin YH; Ministry of Health Holdings, Ministry of Health, Singapore, Singapore., Chew NWS; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Nicholas_WS_Chew@nuhs.edu.sg.; Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. Nicholas_WS_Chew@nuhs.edu.sg.
Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Jul 12; Vol. 24 (1), pp. 285. Date of Electronic Publication: 2025 Jul 12.
Publication Type: Journal Article; Meta-Analysis; Systematic Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40652242
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tang+ASP%22">Tang ASP</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Hsu+JTY%22">Hsu JTY</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chong+SKS%22">Chong SKS</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Quek+J%22">Quek J</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Shek+G%22">Shek G</searchLink>; Wallace Wurth, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Sulaimi+F%22">Sulaimi F</searchLink>; Wallace Wurth, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Chan+KE%22">Chan KE</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Anand+VV%22">Anand VV</searchLink>; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chong+B%22">Chong B</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mehta+A%22">Mehta A</searchLink>; Virginia Commonwealth University Health Pauley Heart Center, Division of Cardiology (A.M.), Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, USA.<br /><searchLink fieldCode="AU" term="%22Toh+SA%22">Toh SA</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Medicine, National University Hospital, Singapore, Singapore.; NOVI Health, Singapore, Singapore.; Regional Health System Office, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Muthiah+M%22">Muthiah M</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Dimitriadis+GK%22">Dimitriadis GK</searchLink>; Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, London, UK.; Obesity, Type 2 Diabetes and Immunometabolism Research Group, Department of Diabetes, Faculty of Cardiovascular Medicine & Sciences, School of Life Course Sciences, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22le+Roux+CW%22">le Roux CW</searchLink>; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.; Diabetes Research Centre , Ulster University , UK, UK.<br /><searchLink fieldCode="AU" term="%22Chan+MY%22">Chan MY</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mamas+MA%22">Mamas MA</searchLink>; Keele Cardiac Research Group, Keele University, Stoke-on-Trent, UK.<br /><searchLink fieldCode="AU" term="%22Chin+YH%22">Chin YH</searchLink>; Ministry of Health Holdings, Ministry of Health, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chew+NWS%22">Chew NWS</searchLink>; NUS Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Nicholas_WS_Chew@nuhs.edu.sg.; Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. Nicholas_WS_Chew@nuhs.edu.sg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101147637%22">Cardiovascular diabetology</searchLink> [Cardiovasc Diabetol] 2025 Jul 12; Vol. 24 (1), pp. 285. <i>Date of Electronic Publication: </i>2025 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Meta-Analysis; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101147637 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1475-2840 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214752840%22">14752840 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Diabetol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40652242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12933-025-02840-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 285
    Titles:
      – TitleFull: Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tang ASP
      – PersonEntity:
          Name:
            NameFull: Hsu JTY
      – PersonEntity:
          Name:
            NameFull: Chong SKS
      – PersonEntity:
          Name:
            NameFull: Quek J
      – PersonEntity:
          Name:
            NameFull: Shek G
      – PersonEntity:
          Name:
            NameFull: Sulaimi F
      – PersonEntity:
          Name:
            NameFull: Chan KE
      – PersonEntity:
          Name:
            NameFull: Anand VV
      – PersonEntity:
          Name:
            NameFull: Chong B
      – PersonEntity:
          Name:
            NameFull: Mehta A
      – PersonEntity:
          Name:
            NameFull: Toh SA
      – PersonEntity:
          Name:
            NameFull: Muthiah M
      – PersonEntity:
          Name:
            NameFull: Dimitriadis GK
      – PersonEntity:
          Name:
            NameFull: le Roux CW
      – PersonEntity:
          Name:
            NameFull: Chan MY
      – PersonEntity:
          Name:
            NameFull: Mamas MA
      – PersonEntity:
          Name:
            NameFull: Chin YH
      – PersonEntity:
          Name:
            NameFull: Chew NWS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 07
              Text: 2025 Jul 12
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1475-2840
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cardiovascular diabetology
              Type: main
ResultId 1